Clinical Trials Logo

Clinical Trial Summary

This pilot study is designed to validate the diagnostic ability of a novel APD for auricular point detection among patients with menstrual migraine (MMG), as compared with an already commercialized device.


Clinical Trial Description

This pilot study is designed to evaluate the diagnostic ability of a novel APD for auricular point detection among patients with menstrual migraine (MMG), as compared with an already commercialized device. The investigators will test if the novel APD could provide a more reliable and quantifiable diagnosis of MMG-related auricular point than traditional devices currently available in the market; The study will also use the APD device to test whether the cutaneous electrical impedance detected from the corresponding auricular points by the novel device is the lowest in the reproductive organ and facial area in the MMG population. As a pilot study, 12 patients with MMG will be recruited from the School of Chinese Medicine, the University of Hong Kong. 12 healthy subjects will be recruited from the university community. Auricular acupoint detection will be accomplished with the new device and a control device. The electrical impedance will be measured and recorded. Patient's condition will also be evaluated by the visual analogue scale (VAS) and the Modified New England Center of Headache (NECH) headache calendar. The specificity and sensitivity of the auricular point detection by the APD device will be calculated. Cohen's kappa coefficient (κ) will be used to test the inter-methods reliability, test-retest reliability, and inter-tester reliability. Moreover, the Pearson Correlation Coefficient will be used to test the correlation between the electrical impedance of the auricular point and the pain intensity score. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03702114
Study type Observational
Source The University of Hong Kong
Contact Mingxiao Yang
Phone +852-6316 1954
Email mingxiaoyang@hotmail.com
Status Not yet recruiting
Phase
Start date October 15, 2018
Completion date March 31, 2019

See also
  Status Clinical Trial Phase
Completed NCT04600388 - Efficacy and Safety of Nerivio for the Acute Treatment of Menstrual Migraine
Not yet recruiting NCT02592681 - Comparison of the Prophylactic Effect Between Acupuncture and Acupressure on Menstrual Migraine N/A
Completed NCT01329562 - CGRP, Estrogen, Cortisol, VIP, α-Amylase, PGE2, PGI2 and ß-Endorphin Levels in Menstrual Migraine Before and After Treximet Phase 4
Recruiting NCT06173661 - Fremanezumab Treatment of Migraine in Women With Menstrual Migraine Ages 18-45 Phase 4
Recruiting NCT03152305 - Intracranial Pressure During Migraine N/A
Completed NCT01578941 - An Investigation of the Safety and Utility of Treximet in the Treatment of Menstrual Migraine Phase 4
Completed NCT04102995 - A Study Investigating the Efficacy and Safety of Sepranolone in Women With Menstrual Migraine Phase 2
Terminated NCT01395264 - Saccadometry in Primary Headache Syndromes N/A
Terminated NCT01114711 - Frovatriptan and Menstrual Migraine